This is unpublished
CoNR: Cross-over Randomized Controlled Trial of Coenzyme Q10 or Nicotinamide Riboside in Chronic Kidney Disease
Completed Studies
CKD
Pinned
Principal Investigator
Bryan Kestenbaum
Funding Agency
NIDDK
Status
Completed
Investigator
What is the CoNR Study?
This is a randomized clinical trial testing two agents that target mitochondria (the energy producing units of muscle): coenzyme Q10 and nicotinamide riboside for improving exercise efficiency in people with chronic kidney disease.